Sarepta Therapeutics (SRPT) EBT Margin Growth (1y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -2,817.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1,558.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -683.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 2,688.00 |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn | 37,337.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37,337.00 |
| Dec 31, 2025 | -7,493.00 |
| Sep 30, 2025 | -5,587.00 |
| Jun 30, 2025 | 2,140.00 |
| Mar 31, 2025 | -29,766.00 |
| Dec 31, 2024 | -4,810.00 |
| Sep 30, 2024 | 1,728.00 |
| Jun 30, 2024 | 6,929.00 |
| Mar 31, 2024 | 21,228.00 |
| Dec 31, 2023 | -13,916.00 |
| Sep 30, 2023 | 11,341.00 |
| Jun 30, 2023 | 4,245.00 |
| Mar 31, 2023 | 27,103.00 |
| Dec 31, 2022 | 26,567.00 |
| Sep 30, 2022 | -9,812.00 |
| Jun 30, 2022 | -5,036.00 |
| Mar 31, 2022 | -35,936.00 |
| Dec 31, 2021 | 77,162.00 |
| Sep 30, 2021 | 84,780.00 |
| Jun 30, 2021 | 52,193.00 |
| Mar 31, 2021 | 1,746.00 |
| Dec 31, 2020 | -60,321.00 |
| Sep 30, 2020 | -74,578.00 |
| Jun 30, 2020 | -28,779.00 |
| Mar 31, 2020 | -4,340.00 |
| Dec 31, 2019 | -6,690.00 |
| Sep 30, 2019 | -2,913.00 |
| Jun 30, 2019 | -14,403.00 |
| Mar 31, 2019 | -3,346.00 |
| Dec 31, 2018 | -12,272.00 |
| Sep 30, 2018 | 131.00 |
| Jun 30, 2018 | 3,263.00 |
| Mar 31, 2018 | -58,133.00 |
| Dec 31, 2014 | -16.44 Mn |
| Sep 30, 2014 | -258,320.00 |
| Jun 30, 2014 | -59,226.00 |
| Mar 31, 2014 | -7,338.00 |
| Dec 31, 2013 | -111,074.00 |
| Sep 30, 2013 | -50,641.00 |
| Jun 30, 2013 | -53,104.00 |
| Mar 31, 2013 | -27,880.00 |